DIVI S LABORATORIES LTD vs MAX HEALTHCARE INS LTD

A side-by-side comparison of DIVI S LABORATORIES LTD (DIVISLAB) and MAX HEALTHCARE INS LTD (MAXHEALTH) — valuation, profitability, growth, and financial health — to help you judge which is the stronger buy today.

The verdict

On the numbers, DIVI S LABORATORIES LTD leads DIVISLAB vs MAXHEALTH on 11 of 14 metrics. See the breakdown below — the right pick still depends on your goals (value vs growth, risk appetite).

Valuation

How expensive each stock is relative to its earnings and book value. Lower usually means cheaper.

74.93
P/E ratio
73.54
10.72
P/B ratio
9.97
0.44%
Dividend yield
0.18%
₹96.73
EPS
₹14.82

Profitability

How efficiently each company turns capital and sales into profit. Higher is better.

16.50%
Return on equity
14.80%
22.00%
Return on capital
15.00%
33.00%
EBITDA margin
27.00%
24.32%
Net margin
17.22%

Growth

Three-year compounded growth. Faster-growing businesses can justify a higher valuation.

10.78%
Revenue CAGR (3Y)
22.43%
12.10%
Profit CAGR (3Y)
9.31%

Size & financial health

Scale and balance-sheet strength. Bigger revenue/profit and lower debt are generally safer.

₹1.92L Cr
Market cap
₹1.06L Cr
₹10,560 Cr
Revenue
₹8,373 Cr
₹2,568 Cr
Net profit
₹1,442 Cr
0.00
Debt / equity
0.32
DIVI S LABORATORIES LTD
  • + ["Company is almost debt free.", "Company has been maintaining a healthy dividend payout of 39.0%"]
  • ["Stock is trading at 10.8 times its book value", "The company has delivered a poor sales growth of 8.67% over past five years."]
MAX HEALTHCARE INS LTD
  • ["Stock is trading at 10.0 times its book value", "Tax rate seems low", "Company has a low return on equity of 13.7% over last 3 years.", "Company might be capitalizing the interest cost", "Dividend payout has been low at 13.6% of profits over last 3 years"]
DIVI S LABORATORIES LTD full analysis MAX HEALTHCARE INS LTD full analysis

This comparison is for informational purposes only and is not investment advice. Please consult a SEBI-registered advisor before investing.